Most Read News

With a revenue potential of ₹350-400 crore, the project would be launched in the early part of FY26.

Here are some of the stocks that may see significant price movement today: BHEL, IRCTC, Birlasoft, Bajaj Healthcare, etc.

Revenue grew by 39% YoY, reaching ₹458.3 crore, compared to ₹330 crore in the same period last year.

The company’s EBITDA surged 78.50% to ₹158.10 Crore in the quarter under review, as compared to ₹88.60 Crore in Q3FY24.

The drug enhances the flow of blood through the lungs, allowing children with PAH to breathe and improve their ability to engage in physical activity.

The fund to invest predominantly in equity and equity related securities of companies engaged in financial services businesses.

The company reported a 13.70% year-on-year growth in its net profit at ₹341 Crore, against ₹300 Crore in the previous comparable quarter.

Ipratropium Bromide Nasal Solution (0.03%) is indicated for the symptomatic relief of rhinorrhea (runny nose) associated with allergic and nonallergic perennial rhinitis.

While Jerome Powell avoided committing to any political outcomes, he persisted with his view that free trade was more growth accretive than tariffs.

The company’s operating EBITDA, witnessed about 9 fold growth to ₹852.20 Crore compared to ₹97.30 Crore.